Duracrin, LLC funding
Duracrin, LLC, a biotechnology company based in New Haven, CT (founded 2025), filed a Form D with the SEC on February 25, 2026 and reported $1M raised.
Amount raised$1M
Offering size$1M
Filed with the SECFebruary 25, 2026
First saleFebruary 3, 2026
IndustryBiotechnology
SecuritiesEquity
LocationNew Haven, CT
Founded2025
Entity typeLimited Liability Company
Investors so far2
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Feb 25